Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Nicorette" (73)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
(Codice) 15 products
WHO-DDD
IP
CM
Ibuprofen Viatris 400 mg
20
1.56
10.95
10 %
Coated tablets: Ibuprofenum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CM
Ibuprofen Viatris 400 mg
50
3.37
12.90
10 %
Coated tablets: Ibuprofenum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
Casgevy 4-13 x 10e6
cells/ml
PR
PR
k.A.
Vertex
Pharmaceuticals (CH)
GmbH
A
FB
G
IP
CI
Ebvallo
PR
PR
k.A.
Pierre Fabre Pharma SA
A
FB
G
L
IP
Bavencio 200 mg/10 ml
827.76
916.65
10 %
Concentrate for infusion: Avelumabum 200mg / 10ml
Merck (Schweiz) AG
A / SL
FB
G
L
IP
Bavencio 200 mg/10 ml
4
3311.04
3617.35
10 %
Concentrate for infusion: Avelumabum 200mg / 10ml
Merck (Schweiz) AG
A / SL
FB
G
L
IP
Vegzelma 100 mg/4 ml
257.57
296.55
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Vegzelma 400 mg/16 ml
962.84
1063.55
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1484.04
1630.40
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Mycamine 50 mg
Durchstechflasche(n)
253.58
292.20
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Micafunginum 50 mg
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Ogivri 150 mg
456.84
513.25
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Medius AG
A / SL
FB
G
IP
CI
Bilaxten 6 mg / ml
5 ml
PR
PR
k.A.
Eye drops: Bilastinum 6 mg/ml
A. Menarini GmbH
B
FB
G
IP
V/S
VeraSeal 4 ml
2 x 2 ml
PR
PR
k.A.
Lösung für Gewebekleber: Fibrinogenum Humanum 160mg / 2ml
Lösung für Gewebekleber: Thrombinum Humanum 1000U.I. / 2ml
Janssen-Cilag AG
B
FB
G
IP
Mylotarg 5 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
IP
Padcev 30 mg
1028.09
1189.05
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Enfortumabum Vedotinum 30 mg
Astellas Pharma AG
A
FB
G
Nicotine (N07BA01) 58 products
WHO-DDD
DrugBank.ca
IP
Nicorette Polar Mint 2 mg
80
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Nicotinell Fruit 2 mg
12 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Nicotinell Cool Mint 2 mg
12 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Nicotinell Fruit 2 mg
24 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Cool Mint 2 mg
24 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Fruit 2 mg
96 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Cool Mint 2 mg
96 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Fruit 2 mg
204 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Cool Mint 2 mg
204 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Fruit 4 mg
12 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Nicotinell Cool Mint 4 mg
12 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Nicotinell Fruit 4 mg
24 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Cool Mint 4 mg
24 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Fruit 4 mg
96 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Cool Mint 4 mg
96 piece(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicorette Polar Mint 2 mg
20
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
Nicorette Polar Mint 2 mg
80
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicotinell Mint 1 mg
36 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 1 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 1 mg
96 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 1 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 1 mg
204 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 1 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 2 mg
36 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 2 mg
96 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 2 mg
204 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Nicorette Microtab
Original-Aroma
100 Tablet(s)
PR
PR
k.A.
Sublingual tablets: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Invisi 10 mg/16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 15.75 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Invisi 15 mg/ 16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 23.62 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Invisi 25 mg/ 16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 39.37 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette 10 mg
42 piece(s)
PR
PR
k.A.
Inhaler: Nicotinum 10 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicotinell
7 plaster(s)
PR
PR
k.A.
Pflaster Stärke: Nicotinum 17.5 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell
21 plaster(s)
PR
PR
k.A.
Pflaster Stärke: Nicotinum 17.5 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell
7 plaster(s)
PR
PR
k.A.
Pflaster Stärke: Nicotinum 35 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell
21 plaster(s)
PR
PR
k.A.
Pflaster Stärke: Nicotinum 35 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell
7 plaster(s)
PR
PR
k.A.
Pflaster Stärke: Nicotinum 52.5 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell
21 plaster(s)
PR
PR
k.A.
Pflaster Stärke: Nicotinum 52.5 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicorette Mint
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
Nicorette Fruit & Mint
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Nicorette Mint
2
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
Nicorette Fruit & Mint
2
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Nicorette Original-Aroma 2 mg
30 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Freshfruit 2 mg
30 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Polar Mint 2 mg
30 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Original-Aroma 2 mg
105 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Freshfruit 2 mg
105 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Polar Mint 2 mg
105 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Freshfruit 2 mg
210 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Nicorette Polar Mint 2 mg
210 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Original-Aroma 4 mg
30 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Freshfruit 4 mg
30 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Polar Mint 4 mg
30 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Original-Aroma 4 mg
105 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Freshfruit 4 mg
105 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Polar Mint 4 mg
105 Tablet(s)
PR
PR
k.A.
wirkstoffhaltiges Kaugummi: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
Nicotimed
7 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 17.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
21 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 17.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
7 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 35 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
21 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 35 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
7 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 52.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
21 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 52.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home